AEON Biopharma, Inc.
AEON · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $5 | $10 | $5 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $1 | $0 | $0 |
| Total Curr. Assets | $2 | $6 | $10 | $5 |
| Property Plant & Equip (Net) | $2 | $1 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2 | $1 | $1 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3 | $7 | $11 | $6 |
| Liabilities | – | – | – | – |
| Payables | $6 | $3 | $8 | $1 |
| Short-Term Debt | $0 | $0 | $71 | $16 |
| Tax Payable | $1 | $1 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $8 | $9 | $4 | $4 |
| Total Curr. Liab. | $14 | $13 | $83 | $21 |
| LT Debt | $13 | $0 | $61 | $71 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $5 | $147 | $138 | $138 |
| Total NC Liab. | $18 | $147 | $199 | $209 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $0 | $0 | $1 |
| Total Liabilities | $32 | $160 | $281 | $230 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$432 | -$474 | -$475 | -$422 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $403 | $321 | $187 | $187 |
| Total Equity | -$29 | -$153 | -$288 | -$235 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $17 | $11 |
| Total Liab. & Tot. Equity | $3 | $7 | $11 | $6 |
| Net Debt | $13 | -$5 | $122 | $82 |